News
Diabetes and weight loss drugs could help treat a type of liver disease. Here's what to know.
A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for diabetes and obesity could also help people with a type of liver disease. CBS News contributor Dr. Celine Gounder explains the findings.
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.
Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...
TikTok creator Janelle Rohner revealed she is taking a GLP-1 medication for weight loss — despite selling $200 courses to ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...
Get your weekly dose of the top news that matters in our newsletter.
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
US Weekly on MSN4d
Everything Influencer Janelle Rohner Has Said About Weight Loss Before GLP-1 ControversyHealth and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using ...
2don MSN
Shares in Hims & Hers Health soared in early-morning trading after it announced a partnership with Wegovy maker Novo Nordisk.
Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback